Phreesia (NYSE:PHR) CFO Sells $43,114.54 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 3,829 shares of the business’s stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $11.26, for a total transaction of $43,114.54. Following the sale, the chief financial officer directly owned 146,740 shares in the company, valued at approximately $1,652,292.40. This represents a 2.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Friday, January 16th, Balaji Gandhi sold 4,687 shares of Phreesia stock. The stock was sold at an average price of $16.36, for a total value of $76,679.32.
• On Thursday, January 15th, Balaji Gandhi sold 975 shares of Phreesia stock. The shares were sold at an average price of $16.38, for a total value of $15,970.50.
• On Thursday, January 8th, Balaji Gandhi sold 8,009 shares of Phreesia stock. The stock was sold at an average price of $17.01, for a total transaction of $136,233.09.

Phreesia Stock Performance

PHR opened at $10.96 on Friday. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01. Phreesia, Inc. has a 12-month low of $10.75 and a 12-month high of $32.76. The firm has a 50 day moving average of $12.61 and a two-hundred day moving average of $17.89. The firm has a market capitalization of $660.54 million, a PE ratio of -109.55 and a beta of 0.67.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on PHR. Wall Street Zen downgraded Phreesia from a “strong-buy” rating to a “buy” rating in a report on Sunday, February 8th. JPMorgan Chase & Co. dropped their price objective on shares of Phreesia from $29.00 to $24.00 and set an “overweight” rating on the stock in a research note on Friday, February 20th. Needham & Company LLC reaffirmed a “buy” rating and set a $35.00 target price on shares of Phreesia in a report on Monday, December 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a research note on Wednesday, January 28th. Finally, Mizuho lowered their price target on shares of Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday. Seventeen equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $28.65.

Institutional Trading of Phreesia

Several institutional investors have recently bought and sold shares of PHR. Federated Hermes Inc. acquired a new position in shares of Phreesia during the 3rd quarter worth approximately $32,000. Van ECK Associates Corp lifted its position in shares of Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after buying an additional 1,102 shares in the last quarter. Asset Management One Co. Ltd. acquired a new stake in Phreesia in the 3rd quarter valued at $45,000. Rockefeller Capital Management L.P. grew its stake in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after acquiring an additional 2,149 shares during the period. Finally, KBC Group NV increased its holdings in Phreesia by 83.4% in the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after acquiring an additional 1,568 shares in the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.